Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report) shares gapped up prior to trading on Monday . The stock had previously closed at $19.9840, but opened at $20.94. Hikma Pharmaceuticals shares last traded at $20.94, with a volume of 215 shares changing hands.
Hikma Pharmaceuticals Stock Performance
The company has a quick ratio of 0.72, a current ratio of 1.24 and a debt-to-equity ratio of 0.33. The business has a fifty day moving average price of $21.30 and a 200 day moving average price of $23.86.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company that develops, manufactures and markets a broad range of branded and non-branded generics, specialty injectables and consumer healthcare products. The company’s three core business segments include generic medicines, injectable products and branded generics, serving hospitals, wholesalers and pharmacies worldwide. Its product portfolio spans diverse therapeutic areas such as cardiovascular, oncology, respiratory, pain management and anti-infectives, with an emphasis on injectable solutions for complex hospital treatments.
Founded in 1978 in Amman, Jordan, Hikma has grown through organic expansion and strategic acquisitions to become one of the leading pharmaceutical players in the Middle East, North Africa, Europe and the United States.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
